A new report, recently published in the International Journal of Cancer, indicates that during the first year of COVID-19, "cancer incidence rates declined for almost all cancer types." While these findings, which also explored impact of COVID-19 pandemic on cancer incidence rates by stage at diagnosis, as well as race and ethnicity, can be attributed to suspension of healthcare during this time, study authors emphasize the importance of "strengthening the return to preventive care campaigns and outreach for detecting cancers at early and more treatable stages."
To read more about this study, click here.
Source mentioned: Schafer EJ, Islami F, Han X, Nogueira LM, Wagle NS, Yabroff KR, Sung H, Jemal A. Changes in cancer incidence rates by stage during the COVID-19 pandemic in the US. Int J Cancer. 2023 Nov 16. doi: 10.1002/ijc.34758. Epub ahead of print. PMID: 37971377.
No comments:
Post a Comment